FDA Issues Class 1 Recall for Artificial Tears Lubricant Eye Drops Contaminated by Deadly Bacteria

FDA Issues Class 1 Recall for Artificial Tears Lubricant Eye Drops Contaminated by Deadly Bacteria

On Behalf of | Feb 9, 2023 | Firm News

On February 2, 2023, Global Pharma Healthcare issued a class 1 recall for Artificial Tears
Lubricant Eye Drops, distributed by EzriCare, and Delsam Pharma due to contamination with a
bacteria known as pseudomonas aeruginosa.

Exposure to pseudomonas can cause serious and permanent injuries, including eye infection,
blindness, and death from bloodstream infection. Many adverse events have already been
reported, including for blindness and death.

Symptoms of exposure include eye discharge, eye pain, redness of the eye or eyelid, the feeling
of something in the eye, increased sensitivity to light or blurry vision, and blindness. The FDA
recommends that anyone having these symptoms that were exposed to the contaminated product
should consult their physician.

The lawyers of Brenes Law Group, P.C. have helped thousands of plaintiffs recover hundreds of
millions of dollars due to defective and/or contaminated products. If you were exposed to these
contaminated eyedrops and suffered an injury, you may be entitled to financial
compensation. Please contact our office as soon as possible to discuss your potential case. There
is no fee or costs to you unless and until we obtain a recovery on your behalf.